GSK brings in Reynolds-MacKenzie, Virgo and Weber Shandwick

Pharmaceutical giant GlaxoSmithKline has enlisted new PR support for two of its most high profile treatments.

GSK: London headquarters
GSK: London headquarters

Healthcare shop Reynolds-MacKenzie has been hired to handle the UK activity for its controversial type 2 diabetes treatment Avandia. Separately, GSK has brought on board Virgo Health PR and Weber Shandwick to handle PR for its cervical cancer vaccine Cervarix.

Reynolds-MacKenzie won the business following a four-way pitch. It is understood that Resolute Communications and Red Door Communications also pitched. There was no incumbent.

Meanwhile, GSK's global Cervarix account was put out to pitch last year (PRWeek, 21 November 2008). Virgo is believed to have won the work following a three-way shoot out. The six-figure account was previously held by Cohn & Wolfe. The brief is understood to include issues work and public affairs activity in most global markets outside the US.

The UK account was also put out to pitch before Christmas and Weber Shandwick was hired in the last week, according to sources at GSK. GSK and the agencies involved declined to comment.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in